BPC-157 is a synthetic 15 amino acid peptide derived from a protective protein found in gastric juice. It is studied in preclinical models for tissue signalling and is not an approved medicine in the EU or the United States. It is supplied as a lyophilised powder for laboratory research, stored cold and protected from light.
For research purposes only. Not for human consumption. This article is educational and references published laboratory research; it is not medical advice and does not describe an approved use of any compound.
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in gastric juice. It is one of the most frequently referenced compounds in preclinical tissue repair literature, and one of the most frequently misdescribed online. This overview separates what the published work actually reports from what it does not.
What BPC-157 is
BPC stands for Body Protection Compound. BPC-157 is a 15 amino acid fragment of a larger protein sequence found in gastric juice. It is produced synthetically for research use and supplied as a lyophilised powder.
The compound is notably stable in aqueous solution compared with many peptides of similar length, which is part of why it appears so often in preclinical protocols.
What the research literature covers
The published body of work on BPC-157 is overwhelmingly preclinical: rodent and in vitro models examining tendon, ligament, muscle and gastrointestinal tissue. Reviews describe investigation into angiogenic signalling and cytoprotection as the proposed mechanisms under study.
What does not exist is a substantial body of controlled human clinical data. Any source presenting BPC-157 as an established human intervention is going beyond the evidence. In research terms this is an active preclinical subject, not a settled one.
BPC-157 and TB-500 in the literature
These two compounds are frequently discussed together because both appear in tissue repair research, but they are structurally unrelated. TB-500 is a synthetic fragment associated with thymosin beta-4 and is studied via actin binding pathways, whereas BPC-157 research centres on angiogenic and cytoprotective signalling.
Combined protocols appear in informal sources far more often than in peer reviewed work. Treat any combination claim as unverified unless it cites a specific study.
Laboratory handling and storage
- Lyophilised vials: refrigerated, protected from light, sealed until use. Frozen for extended storage.
- Reconstitute with bacteriostatic water. Add the diluent slowly against the vial wall.
- Swirl, never shake. Mechanical agitation can degrade peptide structure.
- After reconstitution, store refrigerated and label with the reconstitution date.
- Repeated freeze and thaw cycles are avoided in most protocols. Aliquot if the preparation will be drawn on repeatedly.
Verifying what you have
Batch identity matters more than marketing copy. Every Vitality Peps batch carries a batch reference and an analysis record, published on our lab results page so the batch in your hand can be matched to its report.
Research use only
BPC-157 supplied by Vitality Peps is for in vitro laboratory research. It is not approved as a medicine in the European Union, is not a supplement, and is not for human or veterinary consumption.
Frequently asked questions
Is BPC-157 an approved medicine in the EU?
No. BPC-157 has no marketing authorisation from the EMA or any EU national agency, and it is not approved by the FDA. It is available only as a research chemical, and Vitality Peps supplies it for laboratory use, not for human or veterinary consumption.
What does the research literature actually cover?
Most published work is preclinical: cell culture and rodent studies looking at tissue signalling, blood vessel formation and gut models. Human clinical data is limited to small early-phase reports, so conclusions about effects in people cannot be drawn from the current literature.
How is BPC-157 stored before and after reconstitution?
Lyophilised vials are kept refrigerated at 2 to 8 °C, or frozen for longer storage, away from light. Once reconstituted with bacteriostatic water the solution is kept refrigerated and used within the period set by the laboratory's own protocol; repeated freeze and thaw cycles are avoided.
How can I verify the batch I received?
Check the batch reference on the vial against the current lab report on the Vitality Peps lab results page. The report lists the compound tested, measured mass and HPLC purity and links to the independent laboratory's verification record.
For research purposes only. Not for human consumption. This article is educational and references published laboratory research; it is not medical advice and does not describe an approved use of any compound.
References
- Seiwerth et al., BPC 157 and standard angiogenic growth factors, review
- PubMed, BPC-157 literature index
- Gwyer et al., BPC 157 and accelerated musculoskeletal soft tissue healing, critical review
- Regeneration or risk, a narrative review of BPC-157 for musculoskeletal healing
- Chang et al., BPC 157 and tendon healing, cell survival and migration